Figure 4

The levels of BCoAT gene in patients at baseline and follow-up week-72 (FUw72) in (a) healthy controls, patients with SVR and non-SVR, (b) F0–F1 versus F2–F4 fibrosis stages, (c) HCV monoinfection versus HCV/HIV coinfection, (d) subgroup analysis of fibrosis stages and HIV status.